Brought to you by Population Reports, The INFO Project
Injectable Contraceptives Toolkit
Up-to-date evidence, best practices and related resources to Injectable Contraceptives
Resources for Providers
|
The resources listed here can help family planning providers counsel clients, screen clients to identify medical conditions that would make use of injectables less safe, review guidance for use of injectables among women who have HIV/AIDS, and give injections safely.
|
 |
-
Helping Clients Make a Well-Informed Choice of Injectable Contraceptives
[from "Injectable Contraceptives:Tools for Providers," INFO Reports issue No. 8]Description: Providers can use this table to help counsel women about progestin-only and combined injectables. The table includes information and counseling messages about effectiveness, side effects, safety, and health benefits. -
Helping Clients Be Informed Users of Injectable Contraceptives [from "Injectable Contraceptives:Tools for Providers," INFO Reports issue No. 8]Description: Providers can use this table to help continuing clients use progestin-only or combined injectables successfully. The table includes information and counseling messages to help clients be satisfied users and return on time for their injections.
-
Questions and Answers About Injectables [from "Expanding Services for Injectables," Population Reports issue K-6]Description: Answers to 12 questions that clients might ask about the mechanism of action, side effects, and safety of injectables.
- Decision-Making Tool for Family Planning Clients and Providers Individual Chapters: Long Acting Injectables (DMPA and NET-EN)
and Monthly Injectables [World Health Organization]
Description: This interactive counseling resource is a tool for family planning clients and providers to use together to: help clients choose and use the method of contraception that suits them best; give providers essential information needed to offer high-quality family planning care to clients; and help providers counsel clients more effectively. This tool, which is consistent with the WHO Medical Eligibility Criteria and the Selected Practice Recommendations, contributes to ensure informed free choice and proper use of a method of contraception. - Family Planning: A Global Handbook for Providers [World Health Organization and Johns Hopkins Bloomberg School of Public Health]
Individual chapters: Progestin-Only Injectables and Combined InjectablesDescription: A guide for providing family planning methods, including counseling and managing side effects. Also covers prevention and identification of sexually transmitted infections, including HIV, and numerous health topics related to family planning.
Screening for Medical Eligibility
-
Checklist for Screening Clients Who Want to Initiate DMPA (or NET-EN)
(French) (Spanish) (Romanian) [Family Health International]
Description: A tool from Family Health International designed for use by both clinical and nonclinical health care providers, including community health workers, to help screen clients who were counseled about contraceptive options and made an informed decision to use DMPA. It consists of 13 questions designed to identify medical conditions that would prevent safe DMPA use or require further screening, as well as to provide further guidance and directions based on clients' responses. -
Individual Chapters: Progestin-only contraceptives and Combined injectable contraceptives, patch & ringMedical Eligibility Criteria for Contraceptive Use (Third Edition) (French) (Spanish) (Russian) (Portuguese) [World Health Organization]Description: Guidance on the safety of use of 19 methods for women and men, with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research consensus among experts representing organizations working internationally on reproductive health.
- Selected Practice Recommendations for Contraceptive Use (Second Edition)
(French) (Spanish) [World Health Organization]
Individual Questions:Description: Provides guidance on the safe and effective use of a wide range of contraceptive methods. The recommendations, which answer 33 questions selected by the WHO, were determined by expert consensus and are based on systematic reviews of available clinical and epidemiological research. Seven of the 33 questions address injectable contraceptives and related issues.
-
Women with HIV/AIDS Can Use Injectables [from "Expanding Services for Injectables," Population Reports issue K-6]Description: A summary of the latest research and guidance for use of injectables by women who have HIV/AIDS and women using antiretroviral medications.
-
Checklist for Giving Intramuscular Injections [from "Injectable Contraceptives:Tools for Providers," INFO Reports issue No. 8]
Description: Providers can use this checklist to help ensure injections are given safely. Covers preparation of equipment and supplies, giving the injection, and disposing of waste.
-
Give Injections and Dispose of Waste Safely [from "Expanding Services for Injectables," Population Reports issue K-6]Description: This document reviews the importance of safe injections, the latest injection technology, universal precautions for safe injections, and waste disposal options.
-
Description: This two-page reference document summarizes best practices for safe injections determined through scientific evidence or expert consensus to effectively protect patients, providers, and communities.
-
Description: This course is designed to help health care providers, supervisors of health care facilities, medical students, and nursing students strengthen infection prevention practices in low-resource settings.
Information & Knowledge for Optimal Health (INFO) Project
111 Market Place Suite 310, Baltimore, MD 21202
Phone: 410-659-6300 Fax: 410-659-6266 Security & Privacy Policy
Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.